Physician profile
Andrew Robert Johnson
NPI 1164418943
$653.30
in general payments reported to CMS, 2019-2025
9 companies · $33.04 in 2025
The $33.04 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $16.05 · 2022: $118 · 2023: $355 · 2024: $131 · 2025: $33.04.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $519.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $519.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $196.92 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Janssen Biotech, INC. | $191.98 | 2023-2024 | Stelara, Remicade, Simponi Aria |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $80.02 | 2021-2022 | |
| Aimmune Therapeutics, INC. | $46.67 | 2024-2025 | Zenpep |
| Ardelyx, INC. | $41.13 | 2022 | |
| Ethicon US, LLC | $39.79 | 2023-2024 | Linx Reflux Management System, Echelon Circular |
| Mauna Kea Technologies, INC. | $24.27 | 2024 | |
| Capsovision, INC. | $19.68 | 2023 | Capsocam Plus |
| Nestle Healthcare Nutrition INC. | $12.84 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.